首页> Nature communications> Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.

导出 OA

翻译打印收藏纠错

第一作者： Julia,Boshuizen

第一单位： Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

作者： Julia,Boshuizen ^[1] ; David W,Vredevoogd ^[1] ; Oscar,Krijgsman ^[1] ; Maarten A,Ligtenberg ^[1] ; Stephanie,Blankenstein ^[2] ; Beaunelle,de Bruijn ^[1] ; Dennie T,Frederick ^[3] ; Juliana C N,Kenski ^[1] ; Mara,Parren ^[1] ; Marieke,Brüggemann ^[1] ; Max F,Madu ^[2] ; Elisa A,Rozeman ^[1] ; Ji-Ying,Song ^[4] ; Hugo M,Horlings ^[5] ; Christian U,Blank ^[1] ; Alexander C J,van Akkooi ^[2] ; Keith T,Flaherty ^[6] ; Genevieve M,Boland ^[3] ; Daniel S,Peeper ^[7]

作者单位： Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[1] Division of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[2] Department of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA. ^[3] Division of Animal Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[4] Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[5] Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA. ^[6] Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. d.peeper@nki.nl. ^[7]